News
Use of GLP-1 drugs for weight loss rose sharply in kids and adolescents after the American Academy of Pediatrics in 2023 recommended offering medications along with lifestyle adjustments such as ...
5h
News-Medical.Net on MSNEffective weight loss achieved even with inconsistent GLP-1 accessPopular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research ...
7h
News-Medical.Net on MSNWeight loss drugs can boost testosterone in men with obesity or diabetesAnti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type ...
“While it is well-known that weight loss from lifestyle changes or bariatric surgery increases testosterone levels, the impact that anti-obesity medications may also have on these levels has not been ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
15h
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Experts are warning people using weight-loss jabs could be invalidating travel insurance if they fail to declare the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results